X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (345) 345
Publication (29) 29
Book Review (5) 5
Conference Proceeding (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (299) 299
index medicus (211) 211
oncology (185) 185
male (167) 167
female (166) 166
esophagogastric junction (153) 153
middle aged (152) 152
aged (151) 151
chemotherapy (144) 144
esophageal cancer (144) 144
cancer (136) 136
surgery (127) 127
esophageal neoplasms - pathology (115) 115
adult (109) 109
treatment outcome (103) 103
esophagogastric junction - pathology (97) 97
adenocarcinoma (91) 91
esophageal neoplasms - therapy (83) 83
adenocarcinoma - pathology (79) 79
esophageal neoplasms - drug therapy (78) 78
antineoplastic combined chemotherapy protocols - therapeutic use (75) 75
care and treatment (73) 73
chemoradiotherapy (71) 71
radiotherapy (71) 71
esophageal neoplasms - surgery (67) 67
prognosis (65) 65
gastroenterology & hepatology (64) 64
esophageal neoplasms - mortality (63) 63
squamous-cell carcinoma (62) 62
neoplasm staging (61) 61
esophageal neoplasms - radiotherapy (60) 60
neoadjuvant therapy (60) 60
carcinoma (59) 59
stomach neoplasms - pathology (59) 59
adenocarcinoma - drug therapy (57) 57
survival (57) 57
stomach neoplasms - drug therapy (55) 55
aged, 80 and over (54) 54
esophagus (54) 54
adenocarcinoma - therapy (51) 51
combined modality therapy (50) 50
phase-iii trial (49) 49
adenocarcinoma - mortality (48) 48
cancer therapies (48) 48
gastroesophageal junction (48) 48
research (48) 48
adenocarcinoma - surgery (47) 47
stomach cancer (47) 47
esophagogastric junction - surgery (46) 46
patients (46) 46
gastric cancer (45) 45
tumors (45) 45
retrospective studies (42) 42
radiation therapy (41) 41
esophagogastric junction - radiation effects (40) 40
health aspects (40) 40
perioperative chemotherapy (40) 40
radiology, nuclear medicine & medical imaging (40) 40
therapy (40) 40
disease-free survival (39) 39
antineoplastic combined chemotherapy protocols - adverse effects (38) 38
cisplatin (38) 38
esophagectomy (38) 38
fluorouracil - administration & dosage (38) 38
follow-up studies (38) 38
stomach neoplasms - mortality (38) 38
cisplatin - administration & dosage (37) 37
analysis (36) 36
chemoradiation (35) 35
survival rate (35) 35
mortality (34) 34
risk factors (34) 34
stomach neoplasms - therapy (34) 34
stomach neoplasms - surgery (33) 33
adenocarcinoma - radiotherapy (32) 32
chemotherapy, adjuvant (32) 32
esophagogastric junction - drug effects (32) 32
radiation (32) 32
metastasis (31) 31
radiation-therapy (30) 30
medical prognosis (29) 29
prospective studies (29) 29
randomized-trial (29) 29
advanced esophagogastric cancer (28) 28
clinical trials (28) 28
kaplan-meier estimate (28) 28
neoadjuvant chemotherapy (28) 28
survival analysis (28) 28
carcinoma, squamous cell - therapy (27) 27
esophageal neoplasms - diagnostic imaging (27) 27
usage (27) 27
carcinoma, squamous cell - pathology (26) 26
fluorouracil (26) 26
adjuvant treatment (25) 25
diagnosis (25) 25
stomach neoplasms - radiotherapy (25) 25
antineoplastic agents - therapeutic use (24) 24
esophageal neoplasms - complications (24) 24
positron-emission-tomography (24) 24
trial (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1090 - 1098
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 5, pp. 385 - 391
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 5, pp. 1405 - 1414
Journal Article
Radiation Oncology, ISSN 1748-717X, 01/2015, Volume 10, Issue 1, pp. 16 - 16
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 03/2018, Volume 91, pp. 76 - 85
The optimal time between end of neoadjuvant chemoradiotherapy (nCRT) and oesophagectomy is unknown. The aim of this study was to assess the association between... 
Pathological complete response | Oesophageal surgery | Treatment outcome | Time-to-treatment | Neoadjuvant chemoradiotherapy | Oesophageal carcinoma | SURVIVAL | THERAPY | MORBIDITY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | OUTCOMES | ADVANCED RECTAL-CANCER | Esophagectomy - adverse effects | Multivariate Analysis | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Esophagectomy - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Child, Preschool | Chemoradiotherapy, Adjuvant - adverse effects | Infant | Male | Postoperative Complications - mortality | Chemoradiotherapy, Adjuvant - mortality | Esophageal Neoplasms - pathology | Young Adult | Neoadjuvant Therapy - mortality | Netherlands | Carcinoma, Squamous Cell - mortality | Time Factors | Esophageal Neoplasms - mortality | Adult | Female | Retrospective Studies | Esophageal Neoplasms - therapy | Odds Ratio | Child | Esophagogastric Junction - radiation effects | Infant, Newborn | Databases, Factual | Hospital Mortality | Time-to-Treatment | Risk Factors | Margins of Excision | Carcinoma, Squamous Cell - therapy | Esophagogastric Junction - pathology | Logistic Models | Treatment Outcome | Chi-Square Distribution | Adenocarcinoma - therapy | Esophagogastric Junction - surgery | Neoadjuvant Therapy - adverse effects | Adolescent | Aged | Neoplasm Staging | Adenocarcinoma - mortality
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 56, pp. 115 - 121
Journal Article
Cancer Investigation, ISSN 0735-7907, 02/2016, Volume 34, Issue 2, pp. 57 - 63
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 24, pp. 39727 - 39735
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e54233
Background: Due to low tolerance to chemotherapy, the maximum number of cycles of postoperative adjuvant chemotherapy is 4 in adjuvant gastric clinical trials.... 
PHASE-III TRIAL | ADJUVANT CHEMOTHERAPY | UNITED-STATES | SURGERY | PERIOPERATIVE CHEMOTHERAPY | RESECTABLE GASTRIC-CANCER | MULTIDISCIPLINARY SCIENCES | ASIAN PATIENTS | CURATIVE RESECTION | D2 GASTRECTOMY | COMPARING CAPECITABINE | Esophagogastric Junction - drug effects | Capecitabine | Gastrointestinal Neoplasms - drug therapy | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Epirubicin - administration & dosage | Stomach - surgery | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Adult | Female | Retrospective Studies | Stomach - radiation effects | Stomach - drug effects | Esophagogastric Junction - radiation effects | Adenocarcinoma - radiotherapy | Chemoradiotherapy - methods | Stomach - pathology | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Postoperative Period | Antineoplastic Combined Chemotherapy Protocols | Esophagogastric Junction - pathology | Gastrointestinal Neoplasms - surgery | Adenocarcinoma - drug therapy | Disease-Free Survival | Esophagogastric Junction - surgery | Chemotherapy, Adjuvant - methods | Gastrointestinal Neoplasms - radiotherapy | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Adenocarcinoma | Medical research | Care and treatment | Anthracyclines | Adjuvant treatment | Medical law | Medicine, Experimental | Development and progression | Radiotherapy | Cancer | Fluorouracil | Stomach | Lymphatic system | 5-Fluorouracil | Toxicity | Feasibility studies | Medical services | Clinical trials | Oncology | Radiation therapy | Multivariate analysis | Cancer therapies | Patients | Survival | Stomach cancer | Metastases | Chemotherapy | Medical prognosis | Surgery | Epirubicin | Dissection | Peritoneum
Journal Article